These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 12481384

  • 1. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A, Soltani F, Moshafi MH.
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
    Foroumadi A, Soltani F, Asadipour A.
    Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
    [Abstract] [Full Text] [Related]

  • 4. Antituberculosis agents. III. In vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
    Foroumadi A, Soltani F, Emami S, Davood A.
    Boll Chim Farm; 2002 Apr; 141(3):247-9. PubMed ID: 12197426
    [Abstract] [Full Text] [Related]

  • 5. Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety.
    Foroumadi A, Soltani F, Mirzaei M.
    Pharmazie; 2003 May; 58(5):347-8. PubMed ID: 12779054
    [Abstract] [Full Text] [Related]

  • 6. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [Abstract] [Full Text] [Related]

  • 7. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
    Piersimoni C, Morbiducci V, Bornigia S, De Sio G, Scalise G.
    Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738
    [Abstract] [Full Text] [Related]

  • 9. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
    Ahmad Z, Sharma S, Khuller GK, Singh P, Faujdar J, Katoch VM.
    Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H, Haraguchi Y, Itotani M, Kuroda H, Hashizume H, Tomishige T, Kawasaki M, Matsumoto M, Komatsu M, Tsubouchi H.
    J Med Chem; 2006 Dec 28; 49(26):7854-60. PubMed ID: 17181168
    [Abstract] [Full Text] [Related]

  • 11. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N, Srivastav NC, Desroches N, Agrawal B, Kunimoto DY, Kumar R.
    J Med Chem; 2010 May 27; 53(10):4130-40. PubMed ID: 20420370
    [Abstract] [Full Text] [Related]

  • 12. Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex.
    Heifets LB, Iseman MD, Lindholm-Levy PJ.
    Drugs Exp Clin Res; 1987 May 27; 13(9):529-38. PubMed ID: 3428133
    [Abstract] [Full Text] [Related]

  • 13. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
    Kamala T, Herbert D, Venkatesan P, Paramasivan CN.
    Int J Lepr Other Mycobact Dis; 1997 Sep 27; 65(3):375-8. PubMed ID: 9401493
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS, Raghunathan R, Ekambaram R, Raghunathan M.
    Int J Antimicrob Agents; 2009 Nov 27; 34(5):451-3. PubMed ID: 19625168
    [Abstract] [Full Text] [Related]

  • 15. [A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method].
    Yoshida H, Ano H, Ishida C, Tanigawa N, Kikui M, Takashima T, Tsuyuguchi I.
    Kekkaku; 2002 Jul 27; 77(7):533-5. PubMed ID: 12187818
    [Abstract] [Full Text] [Related]

  • 16. Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance.
    Casal M, Ruiz P, Herreras A.
    Int J Tuberc Lung Dis; 2000 Jun 27; 4(6):588-91. PubMed ID: 10864193
    [Abstract] [Full Text] [Related]

  • 17. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T, Fukuoka T, Doi N, Harasaki T, Inoue H, Hotoda H, Kakuta M, Muramatsu Y, Yamamura N, Hoshi M, Hirota T.
    J Antimicrob Chemother; 2004 Oct 27; 54(4):755-60. PubMed ID: 15347635
    [Abstract] [Full Text] [Related]

  • 18. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB, Lindholm-Levy PJ, Flory M.
    Am Rev Respir Dis; 1991 Feb 27; 143(2):268-70. PubMed ID: 1899326
    [Abstract] [Full Text] [Related]

  • 19. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 27; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives.
    Sriram D, Yogeeswari P, Basha JS, Radha DR, Nagaraja V.
    Bioorg Med Chem; 2005 Oct 15; 13(20):5774-8. PubMed ID: 16039859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.